Emerging entrepreneurs from the University of Toronto and its affiliated hospitals are translating bold scientific ideas into real-world biotech solutions
Financing will support the company’s advancement of its 'dual binding' disease therapy
$25K and $10K will be awarded to the top regenerative or precision medicine innovations
Myoxa Therapeutics and Specifix Dx win the Building a Biotech Venture Pitch Competition
Research grants awarded to products that could impact cancer and rare genetic diseases.
New partnership with Health Innovation Hub offers a focused workshop, expert mentoring, and pitch competition with up to $25,000 in funding on offer to further develop product or venture
